Medication switch
semaglutide → tirzepatide — re-titration required
Semaglutide → tirzepatide for weight loss — strongest head-to-head data favors tirzepatide.
Medically reviewed by Dr. Jane Novak, MD, MPH on May 15, 2026
Cross-ingredient switch — re-titration required
Wegovy uses semaglutide; Zepbound uses tirzepatide. You restart from the starter dose and re-titrate over 12–20 weeks to reduce GI side effects.
These medications use different active ingredients (semaglutide vs. tirzepatide). Re-titration from the starter dose is required to reduce GI side effects.
Start Zepbound 2.5 mg for 4 weeks then escalate to 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg as tolerated. Most patients stabilize at 10 mg or 15 mg for weight management. Full titration from Wegovy 2.4 mg to Zepbound 15 mg is 20 weeks.
Expect nausea and constipation to return during re-titration. The SURMOUNT trials show side-effect rates similar between products at maintenance — the difference is the re-titration period.
Zepbound PA same as Wegovy. Some insurers may consider it a "switch within class" and require new step-through documentation. LillyDirect self-pay vials at $349-$549/month are an option Wegovy does not offer.
Our ranked telehealth providers handle switching prescriptions, prior authorizations, and pharmacy coordination — typically 1–3 business days end to end.
See top providersEditorial ranking is independent of commission rates.
In the SURMOUNT-5 head-to-head trial (Aronne et al., NEJM 2025), tirzepatide 15 mg achieved 20.2% mean weight loss vs. semaglutide 2.4 mg at 14.3% over 72 weeks. Individual response varies; the trial does not predict outcomes in every patient.
Reverse direction
Zepbound → Wegovy
Other from Wegovy
Wegovy → Ozempic
Other from Wegovy
Wegovy → Mounjaro
Other to Zepbound
Mounjaro → Zepbound
Other to Zepbound
Ozempic → Zepbound
Resources for patients moving from Wegovy to Zepbound.
Drug overview
FDA-label overview of Zepbound (tirzepatide) with dosing schedule and contraindications.
ReadDrug overview
What you're switching from. Pricing, indications, and patient experience.
ReadLive data
Check current Zepbound availability and which doses are limited.
ReadFree tool
Decision tree based on FDA criteria. Flags contraindications.
ReadFree tool
Draft a payer-ready PA letter your prescriber can sign in minutes.
ReadRanked & reviewed
Telehealth providers ranked by price, ratings, and insurance.
Read